市場調查報告書

脊柱裂治療全球市場(2019-2025)

Spina Bifida Treatment Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 949549
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
脊柱裂治療全球市場(2019-2025) Spina Bifida Treatment Market 2019-2025
出版日期: 2020年06月08日內容資訊: 英文
簡介

嬰兒疾病的增加和醫學進步推動著全球脊柱裂治療市場的增長。此外,意識的增強,政府支持的增加以及融資和贖回的增加正在推動這一市場的增長。

全球脊柱裂治療市場按類型和治療細分。按類型劃分,市場分為潛伏性,閉孔神經管缺損,腦膜膨出和脊柱腦膜膨出。通過治療,市場被劃分為手術,醫療程序和設備。對於基於手術的分類,市場進一步分為剖腹產,恥骨上膀胱切開術,脊柱外科手術,結腸造口術等等。按照醫療程序,市場分為導尿,導尿和灌腸。

從地理上講,該市場分為四個主要區域,包括北美,歐洲,亞太地區以及世界其他地區(RoW)。預計北美將在全球脊柱裂治療市場中佔有較大的市場佔有率。由於患者人數眾多和健康意識的增強,亞太地區是脊柱裂治療的增長最快的市場。此外,由政府支持的提高認識運動,增加的政府支持以及增加的資金和贖回正在推動市場增長。

Medtronic PLC、Boston Scientific Corp.、Karl Storz SE&Co. KG、Johnson&Johnson Service Inc.、Zimmer Biomet Holdings Inc.、NuVasive Inc.、Smith&Nephew PLC、Stryker Corp和Wellspect Healthcare(Dentsply Sirona Company)脊柱裂是對症治療的領先提供商。市場參與者為提高其全球競爭力而採取的戰略包括合資企業和產品發佈。

本報告調查了全球脊柱裂治療市場,並概述了市場,市場增長因素和阻礙因素分析,市場規模趨勢以及按類型,治療方法和地區,競爭格局和主要趨勢進行的預測。它提供系統信息,例如公司簡介和市場機會。

內容

第1章報告概述

第2章市場概述和見解

  • 調查範圍
  • 分析師見解和當前市場趨勢

第3章競爭情況

  • 公司佔有率分析
  • 主要策略分析
  • 主要公司分析
    • Medtronic PLC
    • Boston Scientific Corp.
    • Karl Storz SE&Co. KG
    • Johnson&Johnson Service、Inc.
    • Zimmer Biomet Holdings、Inc.

第4章市場決定因素

  • 動機
  • 抑制因子
  • 市場機會

第5章市場細分

  • 按類型
    • 潛在性
    • 閉合神經管缺損
    • 腦膜膨出
    • 脊髓腦膜膨出
  • 按治療
    • 手術
    • 醫療
    • 設備

第6章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 其他地區

第7章公司簡介

  • B. Braun Melsungen AG
  • Boston Scientific Corp.
  • C.R. Bard, Inc. (Becton, Dickinson and Co.)
  • Coloplast A/S
  • ConvaTec Group PLC
  • Cook Medical, Inc.
  • Johnson & Johnson Service, Inc.
  • Karl Storz SE & Co. KG
  • Medtronic PLC
  • NuVasive, Inc.
  • Smith & Nephew PLC
  • Stryker Corp.
  • Teleflex, Inc.
  • Wellspect Healthcare (A Dentsply Sirona Company)
  • Zimmer Biomet Holdings, Inc.
目錄
Product Code: OMR2021868

Global Spina Bifida Treatment Market Size, Share & Trends Analysis Report, by Type (Occulta, Closed neural tube defects, Meningocele, and Myelomeningocele), by Treatment (Surgery {Cesarean section, Suprapubic cystostomy, Spinal Surgery, Colostomy, and Others}, Medical Procedure {Urinary catheterization, Urinary diversion, Enema}, and Devices) and Forecast Period 2019-2025

The global spina bifida treatment market is estimated to grow at a CAGR during the forecast period. Growing cases of spina bifida among the infants and medical advancement are driving the growth of the global spina bifida treatment market. Moreover, growing awareness, increasing government assistance, and rising funding and reimbursement are propelling the growth of the global spina bifida market.

The global spina bifida treatment market is segmented based on type and treatment. Based on the type, the market is segmented into occulta, closed neural tube defects, meningocele, and myelomeningocele. And based on the treatment, the market is segmented into surgery, medical procedures, and devices. Furthermore, based on the surgery, the market is further segmented into the cesarean section, suprapubic cystostomy, spinal surgery, colostomy, and others. Based on the medical procedure, the market is segmented into urinary catheterization, urinary diversion, enema.

Based on geography, the market is classified into four major regions, including North America, Europe, Asia-Pacific, and RoW. North America is expected to have a significant market share in the global spina bifida treatment market. Asia-Pacific region is the fastest-growing spina bifida treatment market owing to large numbers of the patient and increasing health awareness. Moreover, growing government-sponsored awareness, increasing government assistance, and rising funding and reimbursement are propelling the growth of the market.

The key players providing spina bifida treatment that includeMedtronic PLC, Boston Scientific Corp., Karl Storz SE & Co. KG, Johnson & Johnson Service, Inc., Zimmer Biomet Holdings, Inc., NuVasive, Inc, Smith & Nephew PLC, Stryker Corp., and Wellspect Healthcare (A Dentsply Sirona Company).The strategies adopted by the market players include joint venture and product launches, to increase their competitiveness across a global scale.

Research Methodology

The market study of the global spina bifida treatmentmarket is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Reports of companies involved in the market
  • Authentic Public Databases
  • Whitepapers such as research papers and news blogs
  • Company websites and their product catalog

The report is intended for providers, suppliers, and distributors of fiberglass, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and will serve as a source for 360-degree analysis of the market.

Market Segmentation-

  • Global Spina Bifida TreatmentMarket Research and Analysis by Type
  • Global Spina Bifida TreatmentMarket Research and Analysis by Treatment

The Report Covers:

  • Comprehensive research methodology of the global spina bifida treatmentmarket.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Insights about market determinants which are stimulating the global spina bifida treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusions

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Medtronic PLC
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Boston Scientific Corp.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Karl Storz SE & Co. KG
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Johnson & Johnson Service, Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Zimmer Biomet Holdings, Inc.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Spina Bifida Treatment Marketby Type
    • 5.1.1. Occulta
    • 5.1.2. Closed neural tube defects
    • 5.1.3. Meningocele
    • 5.1.4. Myelomeningocele
  • 5.2. Global Spina Bifida Treatment Marketby Treatment
    • 5.2.1. Surgery
      • 5.2.1.1. Cesarean section
      • 5.2.1.2. Suprapubic cystostomy
      • 5.2.1.3. Spinal Surgery
      • 5.2.1.4. Colostomy
      • 5.2.1.5. Others
    • 5.2.2. Medical Procedure
      • 5.2.2.1. Urinary Catheterization
      • 5.2.2.2. Urinary Diversion
      • 5.2.2.3. Enema
    • 5.2.3. Devices

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. B. Braun Melsungen AG
  • 7.2. Boston Scientific Corp.
  • 7.3. C.R. Bard, Inc. (Becton, Dickinson and Co.)
  • 7.4. Coloplast A/S
  • 7.5. ConvaTec Group PLC
  • 7.6. Cook Medical, Inc.
  • 7.7. Johnson & Johnson Service, Inc.
  • 7.8. Karl Storz SE & Co. KG
  • 7.9. Medtronic PLC
  • 7.10. NuVasive, Inc.
  • 7.11. Smith & Nephew PLC
  • 7.12. Stryker Corp.
  • 7.13. Teleflex, Inc.
  • 7.14. Wellspect Healthcare (A Dentsply Sirona Company)
  • 7.15. Zimmer Biomet Holdings, Inc.

LIST OF TABLES

  • 1. GLOBAL SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 2. GLOBAL OCCULTA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL CLOSED NEURAL TUBE DEFECTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL MENINGOCELE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL MYELOMENINGOCELE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 7. GLOBAL SPINA BIFIDA SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL CESAREAN SECTION SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL SUPRAPUBIC CYSTOSTOMY SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL SPINAL SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL COLOSTOMY SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBAL OTHER SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. GLOBAL MEDICAL PROCEDURE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 14. GLOBAL URINARY CATHETERIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 15. GLOBAL URINARY DIVERSION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 16. GLOBAL ENEMA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 17. GLOBAL SPINA BIFIDA DEVICE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 18. GLOBAL SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 19. NORTH AMERICAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 20. NORTH AMERICAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 21. NORTH AMERICAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 22. EUROPEAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 23. EUROPEAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 24. EUROPEAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 25. ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 26. ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 27. ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 28. REST OF THE WORLD SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 29. REST OF THE WORLD SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SPINA BIFIDA TREATMENT MARKET SHARE BY TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL SPINA BIFIDA TREATMENT MARKET SHARE BY TREATMENT, 2018 VS 2025 (%)
  • 3. GLOBAL SPINA BIFIDA TREATMENT MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)